Justin Tidwell, DPM
Foot & Ankle Surgery · Portland, ORNPI 1710908892
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (40.6%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 38.7% of the total. Reporting peaked in 2019 at $1,625 and has fallen 96.0% since, to $65 in 2025.
Across 32 payments — averaging $106.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$1K
- KCI USA, Inc.$742
- Stryker$526
- Alafair Biosciences, Inc.$415
- Johnson & Johnson$114
- Organogenesis Inc.$110
- plus $186 from 5 others
What the payments were for
- Consulting fees$50015%
- Speaking & faculty fees$993%
- Travel & lodging$1,18035%
- Food & beverage$1,38741%
- Entertainment$2497%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 8 | $1,322 |
| KCI USA, Inc. | 5 | $742 |
| Stryker | 6 | $526 |
| Alafair Biosciences, Inc. | 2 | $415 |
| Johnson & Johnson | 3 | $114 |
| Organogenesis Inc. | 2 | $110 |
| Smith+Nephew | 1 | $91 |
| Integra Lifesciences Corporation | 2 | $30 |
| Aroa Biosurgery Incorporated | 1 | $28 |
| Polynovo North America LLC | 1 | $21 |
| Zimmer Biomet | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$1,227
- VAC VERAFLO$625
- VersaWrap Tendon Protector$415
- PROstep$385
How this compares
$3,414 in reported general payments places this provider in the 55th percentile of 113 foot & ankle surgery providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 17 | $296 |
| Methylprednisolone | 23 | $205 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 18 | $126 |
| SsdSilver Sulfadiazine | 19 | $124 |
| Terbinafine Hcl | 11 | $98 |
| Silver Sulfadiazine | 29 | $96 |
| Oxycodone Hcl | 12 | $47 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Portland
- Natalie MesnierPortland$339K
- Scott BoyntonPortland$120K
- Andrew ShinabargerPortland$85K
- Kevin DriscollPortland$21K
- John MassoudPortland$14K
- Kenneth HegewaldPortland$11K
- Steven LaxsonPortland$11K
- Lara AtwaterPortland$10K
- Denny lePortland$9K
- Andrew HuPortland$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.